Memscap – 1st quarter 2024 – 04/29/2024 at 6:30 p.m.


2-DIGIT GROWTH IN AERONAUTICAL AND MEDICAL SALES

RECORD QUARTERLY SALES FOR THE AERONAUTICAL ACTIVITY

GROWTH IN NET PROFIT

(15.9% OF TURNOVER)

GROWTH IN ADJUSTED EBITDA1

(21.6% OF TURNOVER)

(Unaudited data)

• Quarterly turnover of 3,832 thousand euros, up 4.5% despite the high volatility of optical communications

• 12.8% increase in aeronautical and medical sales, drivers of growth and profitability for the Group

• Strong growth in the medical sector at 36.4% driven by new applications and historic record for aeronautical activity

• Quarterly adjusted EBITDA of 827 thousand euros (21.6% of turnover)

• Quarterly operating profit of 508 thousand euros (13.3% of turnover)

• Quarterly net profit of the consolidated group of 608 thousand euros (15.9% of turnover)

• 5th consecutive quarter of execution on the 4C plan

• Shareholders and investors video conference – Tuesday April 30, 2024 at 9:00 a.m.



Source link -86